Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jul;85(2):285–292. doi: 10.1054/bjoc.2001.1909

Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse

M El-Abbadi 1, T N Seyfried 1, A J Yates 3, C Orosz 3, M C Lee 2
PMCID: PMC2364034  PMID: 11461091

Abstract

Glycosphingolipid abnormalities have long been implicated in tumour malignancy and metastasis. Gangliosides are a family of sialic acid-containing glycosphingolipids that modulate cell–cell and cell–matrix interactions. Histology and ganglioside composition were examined in a natural brain tumour of the VM mouse strain. The tumour is distinguished from other metastatic tumour models because it arose spontaneously and metastasizes to several organs including brain and spinal cord after subcutaneous inoculation of tumour tissue in the flank. By electron microscopy, the tumour consisted of cells (15 to 20 μm in diameter) that had slightly indented nuclei and scant cytoplasm. The presence of smooth membranes with an absence of junctional complexes was a characteristic ultrastructural feature. No positive immunostaining was found for glial or neuronal markers. The total ganglioside sialic acid content of the subcutaneously grown tumour was low (12.6 ± 0.9 μg per 100 mg dry wt, n= 6 separate tumours) and about 70% of this was in the form of N-glycolylneuraminic acid. In contrast, the ganglioside content of the cultured VM tumour cells was high (248.4 ± 4.4 μg, n= 3) and consisted almost exclusively of N-acetylneuraminic acid. The ganglioside pattern of the tumour grown subcutaneously was complex, while GM3, GM2, GM1, and GD1a were the major gangliosides in the cultured tumour cells. This tumour will be a useful natural model for evaluating the role of gangliosides and other glycolipids in tumour cell invasion and metastasis. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: metastasis, cell culture, brain tumour, sialic acid, gangliosides, macrophages, VM mouse, neuraminic acid

Full Text

The Full Text of this article is available as a PDF (508.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ando S., Yu R. K. Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain. J Biol Chem. 1977 Sep 25;252(18):6247–6250. [PubMed] [Google Scholar]
  2. Ando S., Yu R. K. Isolation and characterization of two isomers of brain tetrasialogangliosides. J Biol Chem. 1979 Dec 10;254(23):12224–12229. [PubMed] [Google Scholar]
  3. Bai H., Seyfried T. N. Influence of ganglioside GM3 and high density lipoprotein on the cohesion of mouse brain tumor cells. J Lipid Res. 1997 Jan;38(1):160–172. [PubMed] [Google Scholar]
  4. Bosmann H. B., Bieber G. F., Brown A. E., Case K. R., Gersten D. M., Kimmerer T. W., Lione A. Biochemical parameters correlated with tumour cell implantation. Nature. 1973 Dec 21;246(5434):487–489. doi: 10.1038/246487a0. [DOI] [PubMed] [Google Scholar]
  5. Brunson K. W., Beattie G., Nicolsin G. L. Selection and altered properties of brain-colonising metastatic melanoma. Nature. 1978 Apr 6;272(5653):543–545. doi: 10.1038/272543a0. [DOI] [PubMed] [Google Scholar]
  6. Coffman R. L., Weissman I. L. B220: a B cell-specific member of th T200 glycoprotein family. Nature. 1981 Feb 19;289(5799):681–683. doi: 10.1038/289681a0. [DOI] [PubMed] [Google Scholar]
  7. Conley F. K. Metastatic brain tumor model in mice that mimics the neoplastic cascade in humans. Neurosurgery. 1984 Feb;14(2):187–192. doi: 10.1227/00006123-198402000-00012. [DOI] [PubMed] [Google Scholar]
  8. Cotterchio M., Seyfried T. N. Serum gangliosides in mice with metastatic and non-metastatic brain tumors. J Lipid Res. 1994 Jan;35(1):10–14. [PubMed] [Google Scholar]
  9. Coulombe J., Pelletier G. Gangliosides and organ-specific metastatic colonization. Int J Cancer. 1993 Jan 2;53(1):104–109. doi: 10.1002/ijc.2910530120. [DOI] [PubMed] [Google Scholar]
  10. Deng W., Li R., Ladisch S. Influence of cellular ganglioside depletion on tumor formation. J Natl Cancer Inst. 2000 Jun 7;92(11):912–917. doi: 10.1093/jnci/92.11.912. [DOI] [PubMed] [Google Scholar]
  11. Eng L. F. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol. 1985 Jun;8(4-6):203–214. doi: 10.1016/s0165-5728(85)80063-1. [DOI] [PubMed] [Google Scholar]
  12. Fang L. H., Lucero M., Kazarian T., Wei Q., Luo F. Y., Valentino L. A. Effects of neuroblastoma tumor gangliosides on platelet adhesion to collagen. Clin Exp Metastasis. 1997 Jan;15(1):33–40. doi: 10.1023/a:1018432306372. [DOI] [PubMed] [Google Scholar]
  13. Flavin H. J., Wieraszko A., Seyfried T. N. Enhanced aspartate release from hippocampal slices of epileptic (El) mice. J Neurochem. 1991 Mar;56(3):1007–1011. doi: 10.1111/j.1471-4159.1991.tb02021.x. [DOI] [PubMed] [Google Scholar]
  14. Fraser H. Astrocytomas in an inbred mouse strain. J Pathol. 1971 Apr;103(4):266–270. doi: 10.1002/path.1711030410. [DOI] [PubMed] [Google Scholar]
  15. Fraser H. Brain tumours in mice, with particular reference to astrocytoma. Food Chem Toxicol. 1986 Feb;24(2):105–111. doi: 10.1016/0278-6915(86)90344-3. [DOI] [PubMed] [Google Scholar]
  16. Fredman P., Wikstrand C. J., Månsson J. E., Reifenberger G., Bigner S. H., Rasheed A., Svennerholm L., Bigner D. D. In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line. Glycoconj J. 1996 Jun;13(3):391–399. doi: 10.1007/BF00731472. [DOI] [PubMed] [Google Scholar]
  17. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 1996 Dec 1;56(23):5309–5318. [PubMed] [Google Scholar]
  18. Kahn H. J., Marks A., Thom H., Baumal R. Role of antibody to S100 protein in diagnostic pathology. Am J Clin Pathol. 1983 Mar;79(3):341–347. doi: 10.1093/ajcp/79.3.341. [DOI] [PubMed] [Google Scholar]
  19. Kanda S., Cochran A. J., Lee W. R., Morton D. L., Irie R. F. Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity. Int J Cancer. 1992 Nov 11;52(5):682–687. doi: 10.1002/ijc.2910520503. [DOI] [PubMed] [Google Scholar]
  20. Kim U., Baumler A., Carruthers C., Bielat K. Immunological escape mechanism in spontaneously metastasizing mammary tumors. Proc Natl Acad Sci U S A. 1975 Mar;72(3):1012–1016. doi: 10.1073/pnas.72.3.1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kloppel T. M., Morré D. J., Jacobsen L. B. Ganglioside patterns of metastatic and non-metastatic transplantable hepatocellular carcinomas of the rat. J Supramol Struct. 1979;11(4):485–492. doi: 10.1002/jss.400110407. [DOI] [PubMed] [Google Scholar]
  22. Ladisch S., Kitada S., Hays E. F. Gangliosides shed by tumor cells enhance tumor formation in mice. J Clin Invest. 1987 Jun;79(6):1879–1882. doi: 10.1172/JCI113031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Laferté S., Fukuda M. N., Fukuda M., Dell A., Dennis J. W. Glycosphingolipids of lectin-resistant mutants of the highly metastatic mouse tumor cell line, MDAY-D2. Cancer Res. 1987 Jan 1;47(1):150–159. [PubMed] [Google Scholar]
  24. Li Y. T., King M. J., Li S. C. Enzymic degradation of gangliosides. Adv Exp Med Biol. 1980;125:93–104. doi: 10.1007/978-1-4684-7844-0_10. [DOI] [PubMed] [Google Scholar]
  25. Manfredi M. G., Lim S., Claffey K. P., Seyfried T. N. Gangliosides influence angiogenesis in an experimental mouse brain tumor. Cancer Res. 1999 Oct 15;59(20):5392–5397. [PubMed] [Google Scholar]
  26. Merritt W. D., Morré D. J., Doak R. L., Keenan T. W. Gangliosides of liver tumors induced by N-2 fluorenylacetamide III. Galactosyl and sialyl transferases in single carcinomas and nodules. Cancer Biochem Biophys. 1980;4(3):183–194. [PubMed] [Google Scholar]
  27. Morgan K. T., Frith C. H., Swenberg J. A., McGrath J. T., Zulch K. J., Crowder D. M. A morphologic classification of brain tumors found in several strains of mice. J Natl Cancer Inst. 1984 Jan;72(1):151–160. doi: 10.1093/jnci/72.1.151. [DOI] [PubMed] [Google Scholar]
  28. Müthing J., Pörtner A., Jäger V. Ganglioside alterations in YAC-1 cells cultivated in serum-supplemented and serum-free growth medium. Glycoconj J. 1992 Oct;9(5):265–273. doi: 10.1007/BF00731138. [DOI] [PubMed] [Google Scholar]
  29. Nicolson G. L. Cell surface molecules and tumor metastasis. Regulation of metastatic phenotypic diversity. Exp Cell Res. 1984 Jan;150(1):3–22. doi: 10.1016/0014-4827(84)90696-7. [DOI] [PubMed] [Google Scholar]
  30. Niederkorn J. Y., Mellon J., Pidherney M., Mayhew E., Anand R. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma. Curr Eye Res. 1993 Apr;12(4):347–358. doi: 10.3109/02713689308999459. [DOI] [PubMed] [Google Scholar]
  31. Pedersen P. H., Rucklidge G. J., Mørk S. J., Terzis A. J., Engebraaten O., Lund-Johansen M., Backlund E. O., Laerum O. D., Bjerkvig R. Leptomeningeal tissue: a barrier against brain tumor cell invasion. J Natl Cancer Inst. 1994 Nov 2;86(21):1593–1599. doi: 10.1093/jnci/86.21.1593. [DOI] [PubMed] [Google Scholar]
  32. Pilkington G. J., Darling J. L., Lantos P. L., Thomas D. G. Tumorigenicity of cell lines (VMDk) derived from a spontaneous murine astrocytoma. Histology, fine structure and immunocytochemistry of tumours. J Neurol Sci. 1985 Dec;71(2-3):145–164. doi: 10.1016/0022-510x(85)90056-5. [DOI] [PubMed] [Google Scholar]
  33. Powers J. M., Liu Y., Moser A. B., Moser H. W. The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol. 1992 Nov;51(6):630–643. doi: 10.1097/00005072-199211000-00007. [DOI] [PubMed] [Google Scholar]
  34. Ruggieri S., Mugnai G., Mannini A., Calorini L., Fallani A., Barletta E., Mannori G., Cecconi O. Lipid characteristics in metastatic cells. Clin Exp Metastasis. 1999 Jun;17(4):271–276. doi: 10.1023/a:1006662811948. [DOI] [PubMed] [Google Scholar]
  35. Said J. W., Hargreaves H. K., Pinkus G. S. Non-Hodgkin's lymphomas: an ultrastructural study correlating morphology with immunologic cell type. Cancer. 1979 Aug;44(2):504–528. doi: 10.1002/1097-0142(197908)44:2<504::aid-cncr2820440221>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  36. Sanchez-Madrid F., Simon P., Thompson S., Springer T. A. Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1. J Exp Med. 1983 Aug 1;158(2):586–602. doi: 10.1084/jem.158.2.586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schackert G., Simmons R. D., Buzbee T. M., Hume D. A., Fidler I. J. Macrophage infiltration into experimental brain metastases: occurrence through an intact blood-brain barrier. J Natl Cancer Inst. 1988 Sep 7;80(13):1027–1034. doi: 10.1093/jnci/80.13.1027. [DOI] [PubMed] [Google Scholar]
  38. Schlaepfer W. W. Neurofilaments: structure, metabolism and implications in disease. J Neuropathol Exp Neurol. 1987 Mar;46(2):117–129. [PubMed] [Google Scholar]
  39. Serano R. D., Pegram C. N., Bigner D. D. Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA). Acta Neuropathol. 1980;51(1):53–64. doi: 10.1007/BF00688850. [DOI] [PubMed] [Google Scholar]
  40. Seyfried T. N., Glaser G. H., Yu R. K. Cerebral, cerebellar, and brain stem gangliosides in mice susceptible to audiogenic seizures. J Neurochem. 1978 Jul;31(1):21–27. doi: 10.1111/j.1471-4159.1978.tb12428.x. [DOI] [PubMed] [Google Scholar]
  41. Seyfried T. N. Perspectives on brain tumor formation involving macrophages, glia, and neural stem cells. Perspect Biol Med. 2001 Spring;44(2):263–282. doi: 10.1353/pbm.2001.0035. [DOI] [PubMed] [Google Scholar]
  42. Seyfried T. N., Yu R. K., Saito M., Albert M. Ganglioside composition of an experimental mouse brain tumor. Cancer Res. 1987 Jul 1;47(13):3538–3542. [PubMed] [Google Scholar]
  43. Seyfried T. N., el-Abbadi M., Ecsedy J. A., Bai H. W., Yohe H. C. Influence of host cell infiltration on the glycolipid content of mouse brain tumors. J Neurochem. 1996 May;66(5):2026–2033. doi: 10.1046/j.1471-4159.1996.66052026.x. [DOI] [PubMed] [Google Scholar]
  44. Seyfried T. N., el-Abbadi M., Ecsedy J. A., Griffin M. E., Yohe H. C. Ganglioside composition of a mouse brain tumor grown in the severe combined immunodeficiency (SCID) mouse. Mol Chem Neuropathol. 1998 Jan;33(1):27–37. doi: 10.1007/BF02815857. [DOI] [PubMed] [Google Scholar]
  45. Seyfried T. N., el-Abbadi M., Roy M. L. Ganglioside distribution in murine neural tumors. Mol Chem Neuropathol. 1992 Oct;17(2):147–167. doi: 10.1007/BF03159989. [DOI] [PubMed] [Google Scholar]
  46. Shapiro W. R. Therapy of adult malignant brain tumors: what have the clinical trials taught us? Semin Oncol. 1986 Mar;13(1):38–45. [PubMed] [Google Scholar]
  47. Skipski V. P., Carter S. P., Terebus-Kekish O. I., Podlaski F. J., Jr, Peterson R. H., Stock C. C. Ganglioside profiles of metastases and of metastasizing and nonmetastasizing rat primary mammary carcinomas. J Natl Cancer Inst. 1981 Dec;67(6):1251–1258. [PubMed] [Google Scholar]
  48. Sung C. C., Pearl D. K., Coons S. W., Scheithauer B. W., Johnson P. C., Zheng M., Yates A. J. Correlation of ganglioside patterns of primary brain tumors with survival. Cancer. 1995 Feb 1;75(3):851–859. doi: 10.1002/1097-0142(19950201)75:3<851::aid-cncr2820750317>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  49. Vinores S. A., Bonnin J. M., Rubinstein L. J., Marangos P. J. Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues. Arch Pathol Lab Med. 1984 Jul;108(7):536–540. [PubMed] [Google Scholar]
  50. Vural G., Hagmar B., Walaas L. Extracranial metastasis of glioblastoma multiforme diagnosed by fine-needle aspiration: a report of two cases and a review of the literature. Diagn Cytopathol. 1996 Jul;15(1):60–65. doi: 10.1002/(SICI)1097-0339(199607)15:1<60::AID-DC12>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  51. Wikstrand C. J., Fredman P., McLendon R. R., Svennerholm L., Bigner D. D. Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro. Mol Chem Neuropathol. 1994 Feb-Apr;21(2-3):129–138. doi: 10.1007/BF02815347. [DOI] [PubMed] [Google Scholar]
  52. Yates A. J. Glycolipids and gliomas. A review. Neurochem Pathol. 1988 Jun;8(3):157–180. [PubMed] [Google Scholar]
  53. Yogeeswaran G. Cell surface glycolipids and glycoproteins in malignant transformation. Adv Cancer Res. 1983;38:289–350. doi: 10.1016/s0065-230x(08)60191-8. [DOI] [PubMed] [Google Scholar]
  54. Yogeeswaran G., Salk P. L. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science. 1981 Jun 26;212(4502):1514–1516. doi: 10.1126/science.7233237. [DOI] [PubMed] [Google Scholar]
  55. Yu R. K., Ledeen R. W. Gas--liquid chromatographic assay of lipid-bound sialic acids: measurement of gangliosides in brain of several species. J Lipid Res. 1970 Nov;11(6):506–516. [PubMed] [Google Scholar]
  56. Zebda N., Pedron S., Rebbaa A., Portoukalian J., Berthier-Vergnes O. Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP-NeuAc:LacCer alpha 2-3 sialyltransferase (GM3 synthase). FEBS Lett. 1995 Apr 3;362(2):161–164. doi: 10.1016/0014-5793(95)00234-z. [DOI] [PubMed] [Google Scholar]
  57. el-Abbadi M., Seyfried T. N. Influence of growth environment on the ganglioside composition of an experimental mouse brain tumor. Mol Chem Neuropathol. 1994 Feb-Apr;21(2-3):273–285. doi: 10.1007/BF02815355. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES